Log in | Register

Bausch + Lomb Names Michael J. Rowe as Corporate Vice President, Human Resources

For the latest pharmaceutical news and updates - Sign up now!
Loading...
THURSDAY, SEPTEMBER 2, 2010


ROCHESTER, N.Y. -- Bausch + Lomb, the global eye health company, has named Michael J. Rowe as corporate vice president, Human Resources.

“Mike is an expert in developing and growing high-performance global teams, having counseled multinational organizations across multiple industries for more than two decades,” said Brent Saunders, chief executive officer, Bausch + Lomb. “As we continue our transformation of B+L, Mike’s leadership will be essential to our success.”

Mr. Rowe was most recently a senior consultant with Proteus International, Inc., where he advised and assisted organizations undertaking dramatic change initiatives. Prior, he was executive vice president, Human Resources, for video game publisher Activision, Inc., from 1999 to 2007. He established the company’s overall HR strategy, practices and programs as it grew into a $3 billion global industry leader.

From 1997 to 1999, Mr. Rowe served as vice president, Human Resources, North America, for Disney Consumer Products, a division of The Walt Disney Co. His HR oversight included merchandise licensing, Disney Interactive, Disney Publishing, Art Classics & Catalog, The Disney Store and global staff functions.

While vice president, Human Resources, for medical transportation service company MedTrans in the mid-1990s, Mr. Rowe led and supported the integration of more than 100 smaller companies. He has also served in leadership roles with PepsiCo Inc., including vice president, Human Resources,
Pepsi-Cola; and senior director, Organizational Learning, and director, Compensation and Benefits, for quick-service restaurant Taco Bell.

Mr. Rowe earned his bachelor’s degree from the University of Michigan and holds a master’s degree in industrial and labor relations from Cornell University. He will be based at Bausch + Lomb’s World Headquarters in Rochester, N.Y.

He replaces Paul H. Sartori, who will retire from Bausch + Lomb later this year after a transition period.

 

SOURCE


Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

When Is Software The Answer To Regulatory Concerns About Your Investigations?

When Is Software The Answer To Regulatory Concerns About Your Investigations?

Jan 30 | John Ager, Technical Consultant, Life Science, Kepner-Tregoe, Inc

Document management software enables investigators to present the information used to reach conclusions clearly and concisely and it helps reviewers to track and approve investigations.

The Benefits of Professional Project Management

The Benefits of Professional Project Management

Jan 13 | Thorsten Vammen, Director at GEA Liquid Processing in Skanderborg, Denmark

Some companies feel that they can project manage new processing facilities themselves, bringing in sub-contracted help only when it’s needed. Self-managing is possible, but there may be a better way.

Multimedia

Battle over Birth Control

Battle over Birth Control

Feb 9 | Video

CNN’s The Situation Room discusses the current dispute over health care coverage for contraception. Will there be a contraception compromise?

Government Seeking $1T Campaign Against Alzheimer's

Government Seeking $1T Campaign Against Alzheimer's

Jan 18 | Video

Government advisors tried to set priorities for a national campaign to treat and manage Alzheimer's disease, which is projected to cost more than a trillion dollars in care by 2050. But as Dr. Jon LaPook reports, the plan does not include any funding.

ADHD Drugs in Short Supply

ADHD Drugs in Short Supply

Jan 11 | Video

Parents of children with attention deficit disorders are forced to travel from pharmacy to pharmacy in search of prescription medicines with no guarantees they will be available.

Study: Link Between Statins And Diabetes

Study: Link Between Statins And Diabetes

Jan 10 | Video

A recent study reveals that women who take statins may have a greate chance of developing diabetes.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter